PAVE PARALLACTIC VISUAL-FIELD ENHANCEMENT DEVICE Trademark

Trademark Overview


On Thursday, November 7, 2024, a trademark application was filed for PAVE PARALLACTIC VISUAL-FIELD ENHANCEMENT DEVICE with the United States Patent and Trademark Office. The USPTO has given the PAVE PARALLACTIC VISUAL-FIELD ENHANCEMENT DEVICE trademark a serial number of 98842168. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 16, 2025. This trademark is owned by NeuroAEye, LLC. The PAVE PARALLACTIC VISUAL-FIELD ENHANCEMENT DEVICE trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus kit comprising a vision treatment and rehabilitation device; apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus kit comprising of a vision treatment and rehabilitation virtual reality device apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus kit comprising of a vision treatment and rehabilitation augmented reality device apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus for neuro-visual disorder assessment, testing, treatment, and rehabilitation incorporating virtual reality headset device and operating system software; medical apparatus for neuro-visual disorder assessment, testing, treatment, and rehabilitation incorporating augmented reality headset device and operating system software; medical treatment and rehabilitation apparatus for treatment and rehabilitatio...
pave parallactic visual-field enhancement device

General Information


Serial Number98842168
Word MarkPAVE PARALLACTIC VISUAL-FIELD ENHANCEMENT DEVICE
Filing DateThursday, November 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical apparatus kit comprising a vision treatment and rehabilitation device; apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus kit comprising of a vision treatment and rehabilitation virtual reality device apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus kit comprising of a vision treatment and rehabilitation augmented reality device apparatus and software for neuro-visual disorder assessment, testing, treatment, and rehabilitation; medical apparatus for neuro-visual disorder assessment, testing, treatment, and rehabilitation incorporating virtual reality headset device and operating system software; medical apparatus for neuro-visual disorder assessment, testing, treatment, and rehabilitation incorporating augmented reality headset device and operating system software; medical treatment and rehabilitation apparatus for treatment and rehabilitation of fields of vision disorders or visual field loss

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuroAEye, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLouisville, KY 40207

Trademark Events


Event DateEvent Description
Thursday, November 7, 2024NEW APPLICATION ENTERED
Saturday, May 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 6, 2025ASSIGNED TO EXAMINER
Friday, May 16, 2025NON-FINAL ACTION WRITTEN
Friday, May 16, 2025NON-FINAL ACTION E-MAILED
Friday, May 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED